Gang,
Apparently, there was a recent article from the hematology/oncology department from Vanderbilt University regarding the efficacy of Xeloda on survival rates. The researcher quoted is Mace Rothenberg. Apparently, the article reports a boost in survivability of patients on Xeloda protocols. Anyone hear about this?
Of course, the million-dollar question is whether this improved survivability is versus the standard protocol for advanced colorectal cancer -- typically FOLFOX. I haven't found that out yet.
Most onc docs I consult have questions regarding the absorption of Xeloda because it is taken orally. For this reason, most docs prefer the infusion form of 5-FU which, let's face it, sucks.
Has anyone either come across this article or has knowledge of other credible data demonstrating improved efficacy of Xeloda versus infusional 5-FU?
thanks,
ketel